May 27, 2026 · Form 4 insider transaction
Hatfield Jeffrey S. bought 16,000 shares of Vir Biotechnology, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
The shares subject to the stock option will vest and become exercisable in full on May 27, 2027.